Skip to main content
. 2023 Oct 4;25(Suppl 4):iv1–iv99. doi: 10.1093/neuonc/noad149

Fig. 9.

Fig. 9

A) Completeness of the Brain Molecular Marker Variablea by Year of Diagnosis and B) Proportion of Individuals with Incomplete Data and Annual Percent Change in Incompleteness, for Selected Histopathologies by ICD-O-3 Code, CBTRUS Statistical Report: US Cancer Statistics—NPCR and SEER, 2018-2020